RBR-4c47pt已完成未知
Development of ursodeoxycholic acid 300 mg at Hospital das Clinicas of FMUSP
Hospital das Clínicas0 个研究点开始时间: 2019年6月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 100Y（—）
入选标准
- •Diagnosis of Primary Biliary Cholangitis; Male or female; 18 years old; and atients on regular treatment for at least 6 months with commercial drug (Ursacol)
排除标准
- •Any other co-existing liver diseases; pregnancy;
- •-withdrawal of consent; patients not adherent to treatment with reference drug and known intolerance to the study drugs
研究者
相似试验
已完成
不适用
Development of Ursodeoxycholic Acid 300 mg at Hospital Das Clinicas of the University of São Paulo School of MedicineUrsodeoxycholic AcidPrimary Biliary CirrhosisNCT03489889University of Sao Paulo General Hospital30
进行中（未招募）
不适用
Pilot study for a trial of ursodeoxycholic acid (UDCA) and/or early delivery for obstetric cholestasis - PITCHEUCTR2007-002717-39-GBniversity of Nottingham200
已完成
不适用
Pilot study for obstetric cholestasis trialObstetric cholestasisPregnancy and ChildbirthOther specified diseases and conditions complicating pregnancyISRCTN37730443niversity of Nottingham (UK)125
已完成
不适用
Clinical study of ursodeoxycholic acid to evaluate the efficacy and safety of ursodeoxycholic acid for the prevention of common bile duct stones following successful removal.Common bile duct stonesJPRN-UMIN000020774Department of General Internal Medicine, Hiroshima University Hospital420
招募中
不适用
The efficacy of Ursodeoxycholic on faster improvement of patients with psoriasisPsoriasis.psoriasis vulgarisIRCT2017092536415N1Tehran University of Medical Sciences30